Arcutis Biotherapeutics, Inc. Common Stock — Quarterly Financial Statements (NASDAQ:ARQT) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Market Capitalization 3.43 B
Employee 342
Founded 2016
CEO Frank Watanabe
Website www.arcutis.com
Headquarter Delaware, United States
FIGI BBG00QN8K4M4
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

3.43 B Market capitalization

Price to earnings ratio

-223.38

Price to sales ratio

9.82

Dividends per share

—

Dividend yield %

—

新闻

Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists

Stock Market Can't Hold Key Levels Amid AI Concerns; Nvidia Tumbles Despite Strong Earnings: Weekly Review

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

Needham上调Arcutis股票目标价至36美元,因销售强劲

Needham raises Arcutis stock price target to $36 on strong sales

H.C. Wainwright上调Arcutis股票目标价,看好Zoryve强劲销售

H.C. Wainwright raises Arcutis stock price target on strong Zoryve sales

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Arcutis 2025年第四季度业绩:ZORYVE推动盈利,营收超预期

Arcutis Q4 2025 slides: ZORYVE drives profitability, revenue beats

Dow Jones Futures Fall Despite Strong Nvidia Earnings After S&P 500 Reclaims Key Level

Arcutis earnings beat by $0.05, revenue topped estimates